Skip to content

Athyrium Capital Management, LP

Follow

13F filer, CIK 1728001, New York, NY

Athyrium Capital Management, LP reported $8,686,216 across 2 holdings for the quarter ended 2024-09-30, in a 13F-HR filed 2024-11-12.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001123292-24-000336

Period
2024-09-30
Reported value
$8.69M
Holdings
2
Top 10 weight
100%
New
0
Sold out
1

Holdings, Q3 2024

Share positions as resolved from 13F-HR 0001123292-24-000336, largest first. % of portfolio is the value over $8,686,216, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
BIORA THERAPEUTICS INCBIORA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: not reported; 2023Q1: 1,694,481 shares; 2023Q2: 1,694,481 shares; 2023Q3: 10,929,762 shares; 2023Q4: 10,929,762 shares; 2024Q1: 10,929,762 shares; 2024Q2: 10,929,762 shares; 2024Q3: 10,929,762 shares 10,929,762$5.48M63.12%0
PBYIPUMA BIOTECHNOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: 1,792,114 shares; 2023Q1: 1,792,114 shares; 2023Q2: 1,792,114 shares; 2023Q3: 1,792,114 shares; 2023Q4: 1,792,114 shares; 2024Q1: 1,256,411 shares; 2024Q2: 1,256,411 shares; 2024Q3: 1,256,411 shares 1,256,411$3.2M36.88%0Timeline

Sold out in Q3 2024

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
COHERUS ONCOLOGY INCCOHERUS ONCOLOGY INC30,000,000$22.2Mprincipal

How Q3 2024 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001123292-24-000336 base2024-11-12acceptance time not in the bulk data set

Filings

Every filing of this filer: 13F reports and notices, the 13D and 13G it filed or is a reporting person of, and Forms 3, 4 and 5 it reported as an owner.

FilingSubjectFiledAcceptedIngested
13F-HR 0001123292-24-000336 Quarter ended 2024-09-302024-11-12acceptance time not in the bulk data set
13F-HR 0001123292-24-000213 Quarter ended 2024-06-302024-08-08acceptance time not in the bulk data set
13F-HR 0001123292-24-000137 Quarter ended 2024-03-312024-05-16acceptance time not in the bulk data set
13F-HR 0001123292-24-000048 Quarter ended 2023-12-312024-02-14acceptance time not in the bulk data set
13F-HR 0001123292-23-000142 Quarter ended 2023-09-302023-11-14acceptance time not in the bulk data set
13F-HR 0001123292-23-000094 Quarter ended 2023-06-302023-08-14acceptance time not in the bulk data set
13F-HR/A 0001123292-23-000059 Quarter ended 2023-03-312023-05-16acceptance time not in the bulk data set
13F-HR 0001123292-23-000057 Quarter ended 2023-03-312023-05-15acceptance time not in the bulk data set
13F-HR 0001567619-23-002883 Quarter ended 2022-12-312023-02-14acceptance time not in the bulk data set
13F-HR 0001567619-22-020018 Quarter ended 2022-09-302022-11-14acceptance time not in the bulk data set
13F-HR 0001567619-22-016220 Quarter ended 2022-06-302022-08-15acceptance time not in the bulk data set
13F-HR 0001567619-22-010942 Quarter ended 2022-03-312022-05-16acceptance time not in the bulk data set
13F-HR 0001567619-22-004383 Quarter ended 2021-12-312022-02-14acceptance time not in the bulk data set
13F-HR 0001567619-21-020429 Quarter ended 2021-09-302021-11-15acceptance time not in the bulk data set
13F-HR 0001567619-21-015856 Quarter ended 2021-06-302021-08-16acceptance time not in the bulk data set
13F-HR 0001567619-21-010489 Quarter ended 2021-03-312021-05-17acceptance time not in the bulk data set
13F-HR 0001567619-21-004054 Quarter ended 2020-12-312021-02-16acceptance time not in the bulk data set
13F-HR 0001567619-19-021532 Quarter ended 2019-09-302019-11-14acceptance time not in the bulk data set
13F-HR 0001567619-19-016973 Quarter ended 2019-06-302019-08-14acceptance time not in the bulk data set
13F-HR 0001567619-19-011205 Quarter ended 2019-03-312019-05-15acceptance time not in the bulk data set
13F-HR 0001567619-19-003291 Quarter ended 2018-12-312019-02-12acceptance time not in the bulk data set
13F-HR 0001567619-18-005817 Quarter ended 2018-09-302018-11-13acceptance time not in the bulk data set
13F-HR 0001567619-18-001098 Quarter ended 2018-06-302018-08-14acceptance time not in the bulk data set
13F-HR 0001140361-18-023961 Quarter ended 2018-03-312018-05-15acceptance time not in the bulk data set
13F-HR 0001140361-18-007635 Quarter ended 2017-12-312018-02-14acceptance time not in the bulk data set